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Toward a Better Understanding of...
The Role of  Notch Signaling on Heart Rate 
and Atrial Conduction Velocity
Somya Bhatnagar
Mentor: Stacey Rentschler
Heart disease is the leading cause of death worldwide and can result in arrhythmias, 
or dysregulation in the electrical activation of the heart. Sick Sinus Syndrome (SSS) is 
characterized by sinus bradycardia (slowed heart rate, HR), slowed conduction through 
atrial myocardium, and can predispose to the development of atrial fibrillation. A 
developmental signaling pathway, Notch, regulates cellular identity through differentiation 
of cardiomyocytes (CMs) into cardiac conduction system-like cells. Previous data 
show that Notch electrically remodels the right atrium, causing slowed conduction 
velocity (CV) and hallmarks of SSS including sinus pauses, sinus bradycardia and a 
predisposition to atrial fibrillation. However, the molecular mechanisms behind these 
phenotypes are not known. We hypothesized that Notch activation produces slowed CV 
through downregulation of major cardiac voltage-gated sodium channel (NaV1.5) and 
atrial gap junction (Connexin40, Cx40). A “Tet-On” doxycycline-activated system using 
transgenic adult mice was used to activate Notch specifically in CMs. We assayed various 
determinants of CV, including fibrosis, cellular hypertrophy, and Na+ channel and gap 
junction expression. Trichrome stain and hydroxyproline assay indicated normal levels 
of non-conductive fibroblasts. To determine whether Notch activation is associated with 
pathophysiological hypertrophy, I quantified cell area using immunohistochemistry 
and found no difference in Notch activated hearts when compared with controls. 
Furthermore, immunohistochemistry indicated no gross changes in NaV1.5 or Cx40 
expression within the atrial myocardium. However, localization of NaV1.5 and Cx40 
within the plasma membranes of CMs, as well as post-translational modifications that 
may result in slowed conduction velocity are yet to be analyzed. Future studies will 
determine whether Notch-induced slowed HR is due to autonomous changes within 
the pace-making sinus node (SAN) region or non-autonomous changes within the 
atrial myocardium. Notch will be activated specifically in the SAN of the adult mouse 
heart using an HCN4-creER tamoxifen-inducible system and HR will be evaluated using 
electrocardiograms.
